Vaccination in the Elderly: What Can Be Recommended?

被引:20
|
作者
Lang, Pierre-Olivier [1 ,2 ]
Aspinall, Richard [1 ]
机构
[1] Cranfield Univ, Cranfield Hlth, Translat Med Res Grp, Cranfield MK43 0AL, Beds, England
[2] Clin Genolier, Nescens Ctr Prevent Med, CH-1272 Genolier, Switzerland
关键词
PNEUMOCOCCAL CONJUGATE VACCINE; ACELLULAR PERTUSSIS-VACCINE; VARICELLA-ZOSTER-VIRUS; PREVENT HERPES-ZOSTER; ADULTS GREATER-THAN-OR-EQUAL-TO-60 YEARS; INACTIVATED INFLUENZA VACCINES; POTENTIAL COST-EFFECTIVENESS; HEPATITIS-A VACCINE; IMMUNE RISK PROFILE; UNITED-STATES;
D O I
10.1007/s40266-014-0193-1
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The age-associated increased susceptibility to infectious disease would suggest that vaccination should be a route to promote healthy aging and keep our seniors autonomous and independent. While vaccination represents a cost-effective and efficient strategy at community level, the ability of the immune system to mount a protective immune response is still unpredictable at the level of the individual. Thus, at a similar age, some individuals, including the elderly, might still be 'good' responders while some other, even younger, would definitely fail to mount a protective response. In this review, the current burden of vaccine-preventable diseases in the aging and aged population will be detailed with the aim to identify the ideal vaccine candidates over the age of 50 years. This article will conclude with potential strategies to reduce, as best as possible, this burden and the imperative need to overcome barriers in extending current vaccine coverage towards to a lifelong vaccine schedule.
引用
收藏
页码:581 / 599
页数:19
相关论文
共 50 条
  • [1] Immune Senescence and Vaccination in the Elderly
    Lang, Pierre Olivier
    Govind, Sheila
    ten Bokum, Annemieke
    Kenny, Natalie
    Matas, Emmanuel
    Pitts, David
    Aspinall, Richard
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (20) : 2541 - 2550
  • [2] Is the new vaccination schedule recommended in France adapted to premature babies?
    Gaudelus, J.
    Pinquier, D.
    Romain, O.
    Thiebault, G.
    le Sage, F. Vie
    Dommergues, M. A.
    Hau, I.
    Bakhache, P.
    Virey, B.
    Dufour, V.
    Parez, N.
    Guerin, N.
    Aujard, Y.
    Weil-Olivier, C.
    Cohen, R.
    ARCHIVES DE PEDIATRIE, 2014, 21 (09): : 1062 - 1070
  • [3] Increasing human papillomavirus vaccination at the recommended age
    Lin, Xia
    Shrader, Lauren
    Rodgers, Loren
    Stokley, Shannon
    Markowitz, Lauri E.
    VACCINE, 2019, 37 (05) : 686 - 689
  • [4] Influenza vaccination in the elderly
    Smetana, Jan
    Chlibek, Roman
    Shaw, Jana
    Splino, Miroslav
    Prymula, Roman
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (03) : 540 - 549
  • [5] Regional differences in recommended cancer treatment for the elderly
    Ho, Vivian
    Ku-Goto, Meei-Hsiang
    Zhao, Hui
    Hoffman, Karen E.
    Smith, Benjamin D.
    Giordano, Sharon H.
    BMC HEALTH SERVICES RESEARCH, 2016, 16
  • [6] Systems Biology of Vaccination in the Elderly
    Duraisingham, Sai S.
    Rouphael, Nadine
    Cavanagh, Mary M.
    Nakaya, Helder I.
    Goronzy, Jorg J.
    Pulendran, Bali
    SYSTEMS BIOLOGY, 2013, 363 : 117 - 142
  • [7] Practical aspects of vaccination in elderly subjects
    de Wazieres, Benoit
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (03): : 255 - 258
  • [8] Vaccination and Inflammatory Arthritis: Overview of Current Vaccines and Recommended Uses in Rheumatology
    Mueller-Ladner, Claudia
    Mueller-Ladner, Ulf
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (06)
  • [9] Immunosenescence and novel vaccination strategies for the elderly
    Dorrington, Michael G.
    Bowdish, Dawn M. E.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [10] The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?
    van Werkhoven, Cornelis H.
    Bonten, Marc J. M.
    FUTURE MICROBIOLOGY, 2015, 10 (09) : 1405 - 1413